← back to search

Susanne Delécluse

German Cancer Research Center · DE
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Viral-associated cancers and disorders, Renal cell carcinoma treatment, Polyomavirus and related diseases, and Lymphoma Diagnosis and Treatment.
h-index
9
citations
339
works
37
NIH funding
primary concept
Medicine
email

Recent publications

Epstein–Barr virus induces aberrant B cell migration and diapedesis via FAK-dependent chemotaxis pathways
Nature Communications 2025cited by 11position: firstdoi
Predictors of Postviral Symptoms Following Epstein-Barr Virus-Associated Infectious Mononucleosis in Young People – Data from the IMMUC Study
medRxiv 2024cited by 2position: middledoi
Epstein-Barr virus infectious particles initiate B cell transformation and modulate cytokine response
mBio 2023cited by 6position: middledoi
Chronic Active Epstein-Barr Virus (EBV) Infection Controlled by Allogeneic Stem Cell Transplantation and EBV-Specific T Cells
Clinical Infectious Diseases 2023cited by 5position: middledoi
BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1
Blood 2022cited by 11position: middledoi
Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy
Nature Communications 2021cited by 64position: middledoi
Metagenomic analysis of primary colorectal carcinomas and their metastases identifies potential microbial risk factors
Molecular Oncology 2021cited by 30position: middledoi
The Epstein–Barr virus noncoding RNA EBER2 transactivates the UCHL1 deubiquitinase to accelerate cell growth
Proceedings of the National Academy of Sciences 2021cited by 26position: middledoi
Efficacy and Safety of Checkpoint Inhibitor Treatment in Patients with Advanced Renal or Urothelial Cell Carcinoma and Concomitant Chronic Kidney Disease: A Retrospective Cohort Study
Cancers 2021cited by 8position: middledoi
Tumorerkrankungen von Dialysepatienten und vor Nierentransplantation
best practice onkologie 2021cited by 0position: firstdoi
EBV-associated primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity
Blood 2020cited by 116position: middledoi
Identification and Cloning of a New Western Epstein-Barr Virus Strain That Efficiently Replicates in Primary B Cells
Journal of Virology 2020cited by 17position: firstdoi
All-cause and cancer-specific overall survival in kidney transplant recipients with pre-transplant malignancies in a German cohort
Journal of Onco-Nephrology 2020cited by 3position: lastdoi
Tumorerkrankungen von Dialysepatienten und vor Nierentransplantation
Der Nephrologe 2020cited by 1position: firstdoi
Einsatz und Nebenwirkungen von Checkpoint-Inhibitoren
Der Nephrologe 2020cited by 0position: firstdoi
Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs
PLoS ONE 2019cited by 12position: firstdoi
EBV+ CNS LYMPHOMAS HAVE A DISTINCTIVE TUMOR MICROENVIRONMENT AND GENETIC PROFILE, WHICH IS AMENABLE TO COMBINATION 3<sup>RD</sup> PARTY EBV‐SPECIFIC CTL AND IBRUTINIB THERAPY
Hematological Oncology 2019cited by 0position: middledoi
Epstein-Barr Virus Induces Expression of the LPAM-1 Integrin in B Cells <i>In Vitro</i> and <i>In Vivo</i>
Journal of Virology 2018cited by 18position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Henri‐Jacques Delecluse · German Cancer Research Center10 papers (2018–2025)Martin Zeier · Heidelberg University6 papers (2018–2021)Rémy Poirey · German Cancer Research Center5 papers (2019–2025)Ming‐Han Tsai · Chang Gung University4 papers (2018–2021)Uta Behrends · Helmholtz Zentrum München4 papers (2018–2024)F. Baccianti · Heidelberg University3 papers (2021–2025)Tim Holland-Letz · Heidelberg University3 papers (2020–2025)Stefanie Zschäbitz · Heidelberg University2 papers (2020–2021)Olcay Cem Bulut · University Hospital Heidelberg2 papers (2018–2019)Anatoliy Shumilov · AstraZeneca (Germany)2 papers (2018–2021)Pierre Sujobert · Laboratoire de Biométrie et Biologie Evolutive2 papers (2022–2025)Zhe Li · Hebei GEO University2 papers (2021–2023)Paul Schnitzler · Heidelberg University2 papers (2019–2020)Carole Soussain · Institut Curie1 papers (2022–2022) · 1 papers (2022–2022)Frank Vari · University of Queensland1 papers (2019–2019)Emily Blyth · The University of Sydney1 papers (2019–2019)Felix Lasitschka · Heidelberg University1 papers (2018–2018)A.B. Steffens · DKFZ-ZMBH Alliance1 papers (2025–2025)Britta Eiz‐Vesper · Medizinische Hochschule Hannover1 papers (2023–2023)